Wesam Taha BasalAbdo Elfiky, and Jehane Eid

Because of the coronavirus pandemic, there have been global efforts to develop suitable treatments; however, there has not been specific antiviral agents suggested. In vivo animal experiments reported that ionotus obliquus, the chaga mushroom, and its bioactive mycochemical constituents have antimicrobial, immunomodulatory, and antiviral properties. Using a molecular docking study, a recent experiment examined the potential antiviral properties of the chaga mushroom against COVID-19. Another study, in silico, explains the ability of the majority of the terpenoid components to interest with the receptor bingo domain of SAR-CoV-2 spike glycoprotein with outstanding rapport.